Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × Immunotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 41 Melanoma 16 Neoplasm Metastasis 15 Lung Neoplasms 14 Neoplasms 11 Carcinoma, Hepatocellular 11 Esophageal Neoplasms 10 Colorectal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Breast Neoplasms 7 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Rectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Recurrence 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Neuroblastoma 2 Neoplasm, Residual 2

Interventions

Temozolomide 107 Radiotherapy 59 Carboplatin 28 Bevacizumab 28 Carmustine 26 Magnetic Resonance Spectroscopy 24 Filgrastim 20 Surgical Procedures, Operative 18 Irinotecan 18 Radiation 16 Lomustine 16 Vincristine 14 Etoposide 13 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Procarbazine 11 Peripheral Blood Stem Cell Transplantation 11 O(6)-benzylguanine 11 Erlotinib Hydrochloride 11 Cyclophosphamide 11 sargramostim 10 Chemotherapy, Adjuvant 10 Cisplatin 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Thiotepa 8 Granulocyte Colony-Stimulating Factor 8 Flucytosine 8 Everolimus 7 vocimagene amiretrorepvec 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06283927 2024-02-28

RECSUR

Erasmus Medical Center

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡